KNSA logo

KNSA EBITDA

Annual EBITDA:

-$43.92M-$21.07M(-92.17%)
December 31, 2024

Summary

  • As of today, KNSA annual EBITDA is -$43.92 million, with the most recent change of -$21.07 million (-92.17%) on December 31, 2024.
  • During the last 3 years, KNSA annual EBITDA has risen by +$110.36 million (+71.53%).
  • KNSA annual EBITDA is now -460.75% below its all-time high of $12.18 million, reached on December 31, 2022.

Performance

1-Year Change

-92.17%

3-Year Change

+71.53%

5-Year Change

+73.84%

15-Year Change

+32.81%

KNSA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

32.81%
KNSA annual EBITDA is higher than 32.81% of companies in Healthcare sector

Range

All-Time High

$12.18M
KNSA annual EBITDA is currently -460.75% below its historical high of $12.18 million

3-Year Low

-$154.28M
KNSA annual EBITDA is currently +71.53% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
KNSA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 3, 2026
KNSA next annual earnings announcement is scheduled for Mar 3, 2026

OtherKNSAincome statement metrics

Annual Revenue

$423.24M
KNSA annual revenue is $423.24 million

Annual Net Income

-$43.19M
KNSA annual net profit is -$43.19 million

Annual EBIT

-$45.62M
KNSA annual earnings before interest & taxes is -$45.62 million

Annual EPS

-$0.60
KNSA annual earnings per share is -$0.60

Quarterly EBITDA:

$24.41M+$3.89M(+18.94%)
September 30, 2025

Summary

  • As of today, KNSA quarterly EBITDA is $24.41 million, with the most recent change of +$3.89 million (+18.94%) on September 30, 2025.
  • Over the past year, KNSA quarterly EBITDA has increased by +$33.66 million (+363.58%).
  • KNSA quarterly EBITDA is now -48.47% below its all-time high of $47.36 million, reached on September 30, 2022.

Performance

3-Month Change

+18.94%

1-Year Change

+363.58%

3-Year Change

-48.47%

5-Year Change

+157.54%

KNSA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

82.84%
KNSA quarterly EBITDA is higher than 82.84% of companies in Healthcare sector

Range

All-Time High

$47.36M
KNSA quarterly EBITDA is currently -48.47% below its historical high of $47.36 million

3-Year Low

-$18.90M
KNSA quarterly EBITDA is currently +229.13% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
KNSA previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 3, 2026
KNSA next earnings announcement is scheduled for Mar 3, 2026

OtherKNSAincome statement metrics

Quarterly Revenue

$180.85M
KNSA quarterly revenue is $180.85 million

Quarterly Net Income

$18.43M
KNSA quarterly net profit is $18.43 million

Quarterly EBIT

$24.02M
KNSA quarterly earnings before interest & taxes is $24.02 million

Quarterly EPS

$0.23
KNSA quarterly earnings per share is $0.23

TTM EBITDA:

$39.64M+$33.66M(+563.23%)
September 30, 2025

Summary

  • As of today, KNSA TTM EBITDA is $39.64 million, with the most recent change of +$33.66 million (+563.23%) on September 30, 2025.
  • Over the past year, KNSA TTM EBITDA has increased by +$64.35 million (+260.46%).
  • KNSA TTM EBITDA is now -6.36% below its all-time high of $42.33 million, reached on June 30, 2023.

Performance

3-Month Change

+563.23%

1-Year Change

+260.46%

3-Year Change

+240.8%

5-Year Change

+129.88%

KNSA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

80.18%
KNSA TTM EBITDA is higher than 80.18% of companies in Healthcare sector

Range

All-Time High

$42.33M
KNSA TTM EBITDA is currently -6.36% below its historical high of $42.33 million

3-Year Low

-$43.92M
KNSA TTM EBITDA is currently +190.26% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
KNSA previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 3, 2026
KNSA next earnings announcement is scheduled for Mar 3, 2026

OtherKNSAincome statement metrics

TTM Revenue

$597.97M
KNSA TTM revenue is $597.97 million

TTM Net Income

$35.92M
KNSA TTM net profit is $35.92 million

TTM EBIT

$38.15M
KNSA TTM earnings before interest & taxes is $38.15 million

TTM EPS

$0.45
KNSA TTM earnings per share is $0.45

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$43.92M
KNSA annual EBITDA is -$43.92 million

Annual Net Income

-$43.19M
KNSA annual net profit is -$43.19 million

Annual Interest Expense

$0.00
KNSA annual interest expense is $0.00

Annual Income Tax

$7.04M
KNSA annual income tax is $7.04 million

Annual D&A

$1.70M
KNSA annual D&A is $1.70 million

KNSA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-92.2%+363.6%+260.5%
3Y3 Years+71.5%-48.5%+240.8%
5Y5 Years+73.8%+157.5%+129.9%

KNSA EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-460.8%+71.5%-48.5%+229.1%-6.4%+190.3%
5Y5-Year-460.8%+73.8%-48.5%+147.2%-6.4%+121.8%
All-TimeAll-Time-460.8%+73.8%-48.5%+136.3%-6.4%+121.8%

KNSA EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$24.41M(+18.9%)
$39.64M(+563.2%)
Jun 2025
-
$20.52M(+50.7%)
$5.98M(+142.0%)
Mar 2025
-
$13.62M(+172.1%)
-$14.23M(+67.6%)
Dec 2024
-$43.92M(-92.2%)
-$18.90M(-104.1%)
-$43.92M(-77.8%)
Sep 2024
-
-$9.26M(-3058.1%)
-$24.70M(+2.6%)
Jun 2024
-
$313.00K(+101.9%)
-$25.37M(+8.7%)
Mar 2024
-
-$16.08M(-5171.3%)
-$27.78M(-27.6%)
Dec 2023
-$22.86M(-287.7%)
$317.00K(+103.2%)
-$21.77M(-45.5%)
Sep 2023
-
-$9.93M(-374.3%)
-$14.96M(-135.3%)
Jun 2023
-
-$2.09M(+79.2%)
$42.33M(+61.9%)
Mar 2023
-
-$10.07M(-241.2%)
$26.15M(+86.9%)
Dec 2022
$12.18M(+107.9%)
$7.13M(-84.9%)
$13.99M(+149.7%)
Sep 2022
-
$47.36M(+359.2%)
-$28.15M(+73.2%)
Jun 2022
-
-$18.27M(+17.8%)
-$105.11M(+16.8%)
Mar 2022
-
-$22.23M(+36.5%)
-$126.38M(+17.2%)
Dec 2021
-$154.28M
-$35.02M(-18.3%)
-$152.55M(+9.9%)
Sep 2021
-
-$29.59M(+25.2%)
-$169.22M(+7.0%)
Jun 2021
-
-$39.54M(+18.3%)
-$182.04M(-4.9%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$48.40M(+6.4%)
-$173.47M(-13.0%)
Dec 2020
-$154.96M(+7.7%)
-$51.69M(-21.9%)
-$153.56M(-15.7%)
Sep 2020
-
-$42.41M(-37.0%)
-$132.67M(-10.4%)
Jun 2020
-
-$30.96M(-8.7%)
-$120.18M(+6.1%)
Mar 2020
-
-$28.49M(+7.5%)
-$128.00M(+23.2%)
Dec 2019
-$167.90M(-55.6%)
-$30.80M(-2.9%)
-$166.68M(+7.3%)
Sep 2019
-
-$29.92M(+22.8%)
-$179.76M(-2.1%)
Jun 2019
-
-$38.78M(+42.3%)
-$175.99M(-10.9%)
Mar 2019
-
-$67.18M(-53.1%)
-$158.72M(-47.1%)
Dec 2018
-$107.87M(-65.0%)
-$43.88M(-67.8%)
-$107.88M(-11.6%)
Sep 2018
-
-$26.15M(-21.5%)
-$96.70M(-11.4%)
Jun 2018
-
-$21.52M(-31.7%)
-$86.79M(-13.2%)
Mar 2018
-
-$16.33M(+50.1%)
-$76.66M(-17.3%)
Dec 2017
-$65.37M(-172.6%)
-$32.70M(-101.4%)
-$65.37M(-100.1%)
Sep 2017
-
-$16.24M(-42.6%)
-$32.67M(-98.9%)
Jun 2017
-
-$11.39M(-125.8%)
-$16.43M(-225.8%)
Mar 2017
-
-$5.04M
-$5.04M
Dec 2016
-$23.98M
-
-

FAQ

  • What is Kiniksa Pharmaceuticals International, plc annual EBITDA?
  • What is the all-time high annual EBITDA for Kiniksa Pharmaceuticals International, plc?
  • What is Kiniksa Pharmaceuticals International, plc annual EBITDA year-on-year change?
  • What is Kiniksa Pharmaceuticals International, plc quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Kiniksa Pharmaceuticals International, plc?
  • What is Kiniksa Pharmaceuticals International, plc quarterly EBITDA year-on-year change?
  • What is Kiniksa Pharmaceuticals International, plc TTM EBITDA?
  • What is the all-time high TTM EBITDA for Kiniksa Pharmaceuticals International, plc?
  • What is Kiniksa Pharmaceuticals International, plc TTM EBITDA year-on-year change?

What is Kiniksa Pharmaceuticals International, plc annual EBITDA?

The current annual EBITDA of KNSA is -$43.92M

What is the all-time high annual EBITDA for Kiniksa Pharmaceuticals International, plc?

Kiniksa Pharmaceuticals International, plc all-time high annual EBITDA is $12.18M

What is Kiniksa Pharmaceuticals International, plc annual EBITDA year-on-year change?

Over the past year, KNSA annual EBITDA has changed by -$21.07M (-92.17%)

What is Kiniksa Pharmaceuticals International, plc quarterly EBITDA?

The current quarterly EBITDA of KNSA is $24.41M

What is the all-time high quarterly EBITDA for Kiniksa Pharmaceuticals International, plc?

Kiniksa Pharmaceuticals International, plc all-time high quarterly EBITDA is $47.36M

What is Kiniksa Pharmaceuticals International, plc quarterly EBITDA year-on-year change?

Over the past year, KNSA quarterly EBITDA has changed by +$33.66M (+363.58%)

What is Kiniksa Pharmaceuticals International, plc TTM EBITDA?

The current TTM EBITDA of KNSA is $39.64M

What is the all-time high TTM EBITDA for Kiniksa Pharmaceuticals International, plc?

Kiniksa Pharmaceuticals International, plc all-time high TTM EBITDA is $42.33M

What is Kiniksa Pharmaceuticals International, plc TTM EBITDA year-on-year change?

Over the past year, KNSA TTM EBITDA has changed by +$64.35M (+260.46%)
On this page